By acquiring Xell, Sartorius is further expanding its cell culture media business with a focus on media for gene therapies and vaccines. In this way, the Group is primarily expanding its capacities for the production of powder and liquid media.
Goettingen/Germany — The life science company Sartorius has acquired the cell culture specialist Xell, based in Bielefeld, Germany, through its subgroup Sartorius Stedim Biotech. Xell develops, produces and markets nutrient media for cell cultures, especially for the production of viral vectors used in gene therapies and vaccines. In addition, the company offers various analytical services to characterize and quantify media components and optimize media formulations.
Previously privately held, Xell employs approximately 35 people and is expected to generate revenues of approximately five million euros in 2021 with strong growth rates and a significant double-digit Ebitda margin. A very extensive and state-of-the-art capacity expansion was recently completed at the company's headquarters. The contractual partners agreed on a purchase price of around 50 million euros plus two earn-out components, which are dependent on the achievement of defined sales targets in the years 2022 to 2025.
Unfold for details of your consent
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.